Medication-Assisted Treatment in Malibu
Table of Contents
- Medication-Assisted Treatment (MAT)
- What Is Medication-Assisted Treatment?
- FDA-Approved Medications Used in MAT
- Who Is a Good Candidate for MAT?
- Our Medication-Assisted Treatment Program
- What to Expect During MAT at LifeSync
- Why MAT Matters in the Opioid Crisis
- Frequently Asked Questions About Medication-Assisted Treatment
Medication-Assisted Treatment (MAT)
Medication assisted therapy or treatment, otherwise known as MAT, is defined as the use of medical therapeutic (medicines) that aid in the sobriety and recovery of the addict or alcoholic. Each person is different, and each person has different needs. Our medical team will address each of your individual needs and work with you to provide the best possible medical care. We will give you the best chance to stay sober for the long-term. Medical science is constantly growing and developing, and new treatment modalities and approaches are being published almost daily. All of our doctors at the SUD level of care are addiction board certified. Dr. Booth is our leader and created the program, and is also there as a liaison and support for our medical team. We can safely and effectively work with you to give you the appropriate treatment that will give you what you need to get sober and stay sober with our LifeSync Programs.
What Is Medication-Assisted Treatment?
Medication-assisted treatment combines medications with counseling and behavioral therapies to treat substance use disorders. According to the Substance Abuse and Mental Health Services Administration, medications can be used to treat substance use disorders, sustain recovery, and prevent overdose. The Substance Abuse and Mental Health Services Administration, part of the U.S. Department of Health and Human Services, supports a whole-patient approach in which medication is one part of a broader treatment plan.
Addiction changes brain chemistry. Over time, opioids and alcohol alter how the brain regulates reward, stress, and motivation, which is why willpower alone rarely overcomes psychological cravings and withdrawal. MAT medications work on these chemical imbalances directly. Some act on opioid receptors to reduce cravings without producing a high, while others block the effects of opioids or alcohol entirely.
How MAT Supports Recovery
Medication addresses the physical aspects of addiction so patients can focus on the psychological and behavioral work of recovery. Medication-assisted treatment (MAT) can help:
- Relieve withdrawal symptoms and reduce cravings
- Lower the risk of opioid overdose and relapse
- Improve treatment retention, so patients stay engaged long enough for therapy to take hold
- Support stable relationships, employment, and daily functioning
- Reduce opioid misuse and related health risks
Research has also linked MAT to a lower risk of HIV and hepatitis C, since people in stable treatment are less likely to inject drugs or share equipment, and to reduced criminal activity as patients regain stable housing, work, and relationships.
A Common Misconception About MAT
A common misconception is that MAT simply trades one drug for another. In reality, MAT medications are prescribed at controlled doses under medical supervision. Buprenorphine and methadone stabilize brain chemistry without the cycle of highs, crashes, and withdrawal that comes with opioid misuse, while naltrexone produces no euphoric effects at all. Used as directed, these medications allow many patients to function normally, think clearly, and fully participate in therapy.
FDA-Approved Medications Used in MAT
The U.S. Food and Drug Administration has approved three medications for the treatment of opioid use disorder: buprenorphine, methadone, and naltrexone. Separate FDA-approved medications are used to treat alcohol use disorder. Our treatment team determines which medication, if any, fits each patient based on a full medical assessment.
Buprenorphine and Suboxone
Buprenorphine is a partial opioid agonist. It binds to opioid receptors in the brain but activates them only partially, which eases withdrawal symptoms and opioid cravings without producing the same euphoric effects as full opioids. As a partial agonist, buprenorphine also has a ceiling effect that limits its effects at higher doses and lowers the risk of misuse and overdose.
Buprenorphine is commonly prescribed as Suboxone, which combines buprenorphine with naloxone, an opioid antagonist that discourages misuse. Learn more about our Suboxone treatment program.
Methadone
Methadone is a long-acting full opioid agonist that reduces cravings and withdrawal symptoms. Under federal rules, methadone for opioid use disorder is dispensed only through certified opioid treatment programs. When methadone is the best fit, our team coordinates with licensed opioid treatment programs to support continuity of care.
Naltrexone
Naltrexone is an opioid antagonist. Rather than activating opioid receptors, it blocks them, preventing the euphoric effects of opioids and reducing the urge to use. Because naltrexone can cause sudden withdrawal in someone who still has opioids in their system, patients must be opioid free for a period of time before starting it. Naltrexone is available as a daily pill or a monthly injection, often known by the brand name Vivitrol. The monthly injection removes the need to take a daily dose, which helps many patients stay consistent.
Medications for Alcohol Use Disorder
MAT is not only for opioids. Several FDA-approved medications help treat alcohol use disorder:
- Naltrexone reduces alcohol cravings and the rewarding effects of drinking, which can lower alcohol consumption
- Acamprosate helps people who have stopped drinking maintain abstinence by easing lingering psychological discomfort
- Disulfiram causes an unpleasant physical reaction if alcohol is consumed, discouraging drinking
Because alcohol withdrawal can be dangerous, patients who drink heavily may need medically supervised detox before starting medication.
Who Is a Good Candidate for MAT?
MAT may be appropriate for adults with a diagnosis of opioid use disorder or alcohol use disorder, particularly those who:
- Have experienced intense cravings or withdrawal symptoms when trying to stop
- Have relapsed after previous attempts at abstinence-based treatment
- Have survived an opioid overdose or are at high risk of one
- Use fentanyl, heroin, prescription pain relievers, or other opioids daily
- Have co-occurring mental health conditions that complicate recovery
MAT is not the right choice for everyone. Some medical conditions, medications, or substance use patterns require a different approach, and some patients prefer to pursue recovery without medication. Our physicians review each patient’s history and goals before recommending any medication, and patients are part of every decision. Patients who cannot take a particular medication because of side effects or allergies have other options our team can discuss.
Our Medication-Assisted Treatment Program
At LifeSync, medication-assisted treatment is part of a complete addiction treatment program rather than a standalone prescription. Unlike many outpatient MAT programs, where patients receive a prescription and return home the same day, our residential setting provides daily medical oversight while we establish and adjust dosing. Our approach treats the whole person, combining medication with therapy, psychiatric care, and support services in one place.
Assessment and Individualized Treatment Plans
Treatment begins with a full evaluation of substance use history, medical conditions, mental health, and prior treatment. Our physicians use that assessment to decide whether MAT is appropriate, which medication fits best, and how to adjust dosing over time. We review treatment plans regularly as patients progress.
Medical Detox and Stabilization
Some patients need medically supervised detox before beginning MAT. Our detox program manages opioid withdrawal and alcohol withdrawal safely, with around-the-clock monitoring and medications that relieve discomfort and reduce the risk of complications, so patients can transition into medication and therapy.
Behavioral Therapies
Medication treats the physical aspects of addiction, while behavioral therapies address the thoughts, emotions, and habits that drive substance use. Patients participate in individual therapy, group therapy, and psychoeducation, using evidence-based approaches such as cognitive behavioral therapy and dialectical behavior therapy.
Dual Diagnosis Care
Many people seeking substance abuse treatment also live with depression, anxiety, trauma, or other mental health conditions. Our dual diagnosis treatment program addresses both within one coordinated plan.
Aftercare and Long-Term Recovery
Before discharge, our team builds an aftercare plan that may include an outpatient prescriber to continue medication, ongoing therapy, support groups, and relapse prevention planning. Continuing medication after residential care helps many patients sustain recovery during the first months at home, when tolerance is lower and the risk of opioid overdose is highest. Our team stays involved in the transition so each patient’s recovery journey continues without gaps in care.
What to Expect During MAT at LifeSync
For many people seeking treatment, not knowing what happens next is a barrier in itself. Here is what the process typically looks like at LifeSync:
- Admission and assessment: Our admissions team gathers your history, verifies insurance, and schedules your arrival. On admission, a physician completes a full medical and psychiatric evaluation.
- Detox and induction: If needed, medically supervised detox manages opioid withdrawal or alcohol withdrawal. For patients starting buprenorphine, a partial opioid agonist, induction is timed carefully to avoid precipitated withdrawal.
- Stabilization: Physicians monitor how you respond and adjust the dose. These medications relieve withdrawal symptoms and cravings so you can sleep, eat, and engage in therapy.
- Therapy and skill building: Individual therapy and group therapy address the behaviors, relationships, and stressors tied to substance use disorders.
- Discharge planning: Before you leave, our team connects you with an outpatient prescriber and continuing care so your MAT treatment continues without interruption.
Unlike many treatment programs that focus only on medication or only on therapy, our program brings both together under one medical team.
Why MAT Matters in the Opioid Crisis
Opioid related overdose deaths remain one of the most serious public health challenges in the country. According to the Centers for Disease Control and Prevention, an estimated 80,391 people died of drug overdoses in the United States in 2024, and 54,743 of those deaths involved opioids. While overdose deaths declined from the year before, opioids still account for most of them.
Many opioid addictions begin with prescription pain relievers, and some people who become dependent on them later turn to heroin or fentanyl when prescriptions end. MAT treats opioid addiction at its source by stabilizing opioid receptors, reducing the drive to use, and giving people time to rebuild their lives. For people with opioid use disorder (OUD), MAT is one of the most effective ways to lower the risk of overdose.
Public health agencies, including the CDC and the Substance Abuse and Mental Health Services Administration, have prioritized expanding access to MAT as a way to reduce opioid related overdose deaths. Yet many people with opioid use disorder (OUD) still never receive medication. Removing that barrier is one of the most practical steps toward treating opioid addiction and reducing drug use at the community level.
Frequently Asked Questions About Medication-Assisted Treatment
Medication-assisted treatment is the use of FDA-approved medications, combined with counseling and behavioral therapies, to treat substance use disorders. It is most often used to treat opioid use disorder (OUD) and alcohol use disorder.
For opioid use disorder, the three FDA-approved medications are buprenorphine, methadone, and naltrexone. For alcohol use disorder, common medications include naltrexone, acamprosate, and disulfiram.
No. Suboxone is one medication used in MAT. Medication-assisted treatment is the broader approach of combining medication with therapy and support. Suboxone treatment is one type of MAT treatment and a common form of opioid addiction treatment.
No. MAT is also used to treat alcohol addiction with medications such as naltrexone, acamprosate, and disulfiram.
Many health agencies now use “medications for opioid use disorder” (MOUD) or “medications for alcohol use disorder” (MAUD). The newer terms emphasize medication as a core part of treatment. “Medication-assisted treatment” and “MAT” are still widely used.
Physicians, nurse practitioners, and physician assistants with the appropriate DEA registration can prescribe buprenorphine to treat opioid use disorder. The federal buprenorphine waiver requirement was eliminated in 2023, expanding access to care. Methadone for opioid use disorder is available only through certified opioid treatment programs.
Research consistently shows that MAT reduces opioid use, overdose deaths, and relapse while improving treatment retention. Results are strongest when medication is combined with behavioral therapies and ongoing support, which is why OUD treatment at LifeSync always includes therapy alongside medication.
There is no fixed timeline. Some patients take medication for several months, while others benefit from longer maintenance. Stopping too early can increase the risk of relapse and overdose, so any change in dosing should be planned with a physician. Residential care typically lasts 30 to 90 days, and medication often continues afterward through an outpatient prescriber.
Like any medication, MAT medications can cause negative effects. Common side effects include nausea, headache, constipation, and sleep changes, depending on the medication. Our medical team monitors each patient closely and adjusts treatment as needed.
Most health insurance plans include some coverage for medication-assisted treatment and addiction treatment, though benefits vary. Our team can verify your coverage before admission.
Sources
- Centers for Disease Control and Prevention. (2025, May 14). U.S. overdose deaths decrease almost 27% in 2024. National Center for Health Statistics. https://www.cdc.gov/nchs/pressroom/releases/20250514.html
- Substance Abuse and Mental Health Services Administration. (n.d.). Substance use disorder treatment options. https://www.samhsa.gov/substance-use/treatment/options
- U.S. Food and Drug Administration. (n.d.). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud
- Substance Abuse and Mental Health Services Administration. (n.d.). Waiver elimination (MAT Act). https://www.samhsa.gov/substance-use/treatment/resources/mat-act
PPO Insurance May Help Cover Treatment
Many PPO insurance plans include benefits for medication-assisted treatment and residential addiction treatment. Our team will review your insurance, explain any out-of-pocket costs, and answer your questions confidentially. If you prefer not to use insurance for added privacy, private pay rates are available for 30, 60, or 90 days.
Start Your Recovery Today
If you or someone you love is struggling with opioid or alcohol use, medication-assisted treatment can make stopping safer and more manageable. Contact our admissions team at (866) 491-4426 or complete the form below for a confidential conversation about medication-assisted treatment at LifeSync Malibu.